MIRA INFORM REPORT

 

 

Report Date :

25.02.2013

 

IDENTIFICATION DETAILS

 

Name :

TATEYAMA KASEI SHOJI CO LTD

 

 

Registered Office :

Itoyoshi Bldg 3F, 2-5-9 Doshomachi Chuoku Osaka 541-0045

 

 

Country :

Japan

 

 

Financials (as on) :

31.05.2012

 

 

Date of Incorporation :

July 1982

 

 

Com. Reg. No.:

1200-01-084094 (Osaka-Chuoku)

 

 

Legal Form :

Limited Company

 

 

Line of Business :

Import, export, wholesale of pharmaceutical intermediates, chemicals

 

 

No. of Employees :

08

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory 

Payment Behaviour :

No Complaints

Litigation :

Clear 

 


NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30th, 2012

                                                   

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

Japan

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

japan - ECONOMIC OVERVIEW

 

In the years following World War II, government-industry cooperation, a strong work ethic, mastery of high technology, and a comparatively small defense allocation (1% of GDP) helped Japan develop a technologically advanced economy. Two notable characteristics of the post-war economy were the close interlocking structures of manufacturers, suppliers, and distributors, known as keiretsu, and the guarantee of lifetime employment for a substantial portion of the urban labor force. Both features are now eroding under the dual pressures of global competition and domestic demographic change. Japan's industrial sector is heavily dependent on imported raw materials and fuels. A tiny agricultural sector is highly subsidized and protected, with crop yields among the highest in the world. Usually self-sufficient in rice, Japan imports about 60% of its food on a caloric basis. Japan maintains one of the world's largest fishing fleets and accounts for nearly 15% of the global catch. For three decades, overall real economic growth had been spectacular - a 10% average in the 1960s, a 5% average in the 1970s, and a 4% average in the 1980s. Growth slowed markedly in the 1990s, averaging just 1.7%, largely because of the after effects of inefficient investment and an asset price bubble in the late 1980s that required a protracted period of time for firms to reduce excess debt, capital, and labor. Measured on a purchasing power parity (PPP) basis that adjusts for price differences, Japan in 2011 stood as the fourth-largest economy in the world after second-place China, which surpassed Japan in 2001, and third-place India, which edged out Japan in 2011. A sharp downturn in business investment and global demand for Japan's exports in late 2008 pushed Japan further into recession. Government stimulus spending helped the economy recover in late 2009 and 2010, but the economy contracted again in 2011 as the massive 9.0 magnitude earthquake in March disrupted manufacturing. Electricity supplies remain tight because Japan has temporarily shut down almost all of its nuclear power plants after the Fukushima Daiichi nuclear reactors were crippled by the earthquake and resulting tsunami. Estimates of the direct costs of the damage - rebuilding homes, factories, and infrastructure - range from $235 billion to $310 billion, and GDP declined almost 0.5% in 2011. Prime Minister Yoshihiko NODA has proposed opening the agricultural and services sectors to greater foreign competition and boosting exports through membership in the US-led Trans-Pacific Partnership trade talks and by pursuing free-trade agreements with the EU and others, but debate continues on restructuring the economy and reining in Japan's huge government debt, which exceeds 200% of GDP. Persistent deflation, reliance on exports to drive growth, and an aging and shrinking population are other major long-term challenges for the economy.

 

 

Source : CIA

 

 

 


Company name  

 

TATEYAMA KASEI SHOJI CO LTD

 

 

REGD NAME

 

Tateyama Kasei Shoji KK

 

 

MAIN OFFICE

 

Itoyoshi Bldg 3F, 2-5-9 Doshomachi Chuoku Osaka 541-0045 JAPAN

Tel: 06-6223-0223      Fax: 06-6223-0212

 

URL:                             http://www.tateyamakasei.com

E-Mail address:                        tks_osaka@tateyamakasei.com

 

 

ACTIVITIES

 

Import, export, wholesale of pharmaceutical intermediates, chemicals, other

 

 

BRANCHES   

 

Tokyo

 

 

OFFICERS

 

IWAO KATGUCHI, PRES

Minoru Kataguchi, ch    

           

Yen Amount:     In million Yen, unless otherwise stated

 

 

SUMMARY

 

FINANCES                    FAIR                             A/SALES          Yen 4,251 M

PAYMENTS                  No complaints          CAPITAL           Yen 15 M

TREND             SLOW                          WORTH            Yen 341 M

STARTED                     1982                             EMPLOYES      8

 

COMMENT    

 

TRADING FIRM SPECIALIZING IN PHARMACEUTICAL INTERMEDIATES,  OWNED BY TATEYAMA KASEI CO LTD.

 

FINANCIAL SITUATION CONSIDERED FAIR AND GOOD FOR ORDINARY BUSINESS ENGAGEMENTS.

                       

 

HIGHLIGHTS

 

The subject company was established on the basis of a trading division separated from Tateyama Kasei Co Ltd (See REGISTRATION).  This is a trading firm specializing in import, export and wholesale of pharmaceutical intermediates, chemical products, resins, other (see OPERATION).  Goods are more exported than imported.  Clients include pharmaceutical makers, chemical makers, other

 

 

FINANCIAL INFORMATION

 

The sales volume for May/2012 fiscal term amounted to Yen 4,251 million, an 11% down from Yen 4,758 million in the previous term.  High Yen hurt export revenues and profits in Yen terms.  The recurring profit was posted at Yen 25 million and the net profit at Yen 21 million, respectively, compared with Yen 49 million recurring profit and Yen 33 million net profit, respectively, a year ago.

 

For the current term ending May 2013 the recurring profit is projected at Yen 40 million and the net profit at Yen 25 million, respectively, on a 2% rise in turnover, to Yen 4,350 million.  .

 

The financial situation is considered FAIR and good for ORDINARY business engagements. 

 

 

REGISTRATION

 

Date Registered:  Jul 1982

Regd No.:         1200-01-084094 (Osaka-Chuoku)

Legal Status:      Limited Company (Kabushiki Kaisha)

Authorized:         5,520 shares

Issued:             1,380 shares

Sum:                   Yen 15 million

Major shareholders (%): Tateyama Kasei Co Ltd* (100)

 

*.. Mfr of pharmaceuticals intermediates, Toyama, founded 1953, capital Yen 80 million, sales Yen 3,795 million, net profit Yen 149 million, employees 147, pres Makoto Kataguchi

 

Nothing detrimental is known as to the commercial morality of executives.

 

 

OPERATION

           

Activities: Imports, exports and wholesales pharmaceutical intermediates, acid esters, resins, cleaning agents for semiconductors, other chemical products (--100%)

 

Clients: [Mfrs, wholesalers] Tateyama Kasei Co, Astellas Pharma Inc, Takeda Pharmaceutical Co, Fuji Film Holdings, Eisai Corp, Daiichi Sankyo Co, Dainippon Sumitomo Pharma Co, Japan Tobacco Inc, Otsuka Pharmaceutical Co, other

            No. of accounts: 500

            Domestic areas of activities: Nationwide

 

Suppliers: [Mfrs, wholesalers] Mitsubishi Tanabe Pharma Corp, Tateyama Kasei Co, Astellas Pharma Inc, Asahi Kasei Trading, Air Water Inc, Toyobo Co, Tokuyama Corp, Daicel Corp, API Corp, Otsuka Chemical Co, other

 

Payment record: No Complaints

 

Location: Business area in Osaka.  Office premises at the caption address are leased and maintained satisfactorily.

 

Bank References:

Hokuriku Bank (Osaka)

MUFG (Semba-Chuo)

Relations: Satisfactory

 

 


FINANCES

(In Million Yen)

 

       Terms Ending:

31/05/2013

31/05/2012

31/05/2011

31/05/2010

Annual Sales

 

4,350

4,251

4,758

4,827

Recur. Profit

 

40

35

49

 

Net Profit

 

25

21

33

32

Total Assets

 

 

775

857

987

Current Assets

 

 

737

814

 

Current Liabs

 

 

427

529

 

Net Worth

 

 

347

328

297

Capital, Paid-Up

 

 

15

15

15

Div.P.Share(¥)

 

 

 

 

 

<Analytical Data>

(%)

(%)

(%)

(%)

    S.Growth Rate

2.33

-10.66

-1.43

2.22

    Current Ratio

 

..

172.60

153.88

..

    N.Worth Ratio

..

44.77

38.27

30.09

    R.Profit/Sales

 

0.92

0.82

1.03

..

    N.Profit/Sales

0.57

0.49

0.69

0.66

    Return On Equity

..

6.05

10.06

10.77

 

Notes: Forecast (or estimated) figures for the 31/05/2013 fiscal term.

 


FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.43

UK Pound

1

Rs.83.20

Euro

1

Rs.71.91

 

INFORMATION DETAILS

 

Report Prepared by :

MNL

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.